Dr. Renan Amador is a Pembroke Pines, Florida based male rheumatologist with 17 years of experience in Rheumatology. He completed his graduation from Other in 2007. He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Renan Amador for Rheumatology is 151659 in Florida. Dr. Renan Amador treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Renan Amador speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
3072909605
Enrollment ID:
I20220407002773
NPI Number:
1487219721
NPI Enumeration Date:
02 May, 2019
NPI Last Update On:
10 Nov, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Renan Amador are as mentioned below.
License Number
Specialization
State
Status
151659
Rheumatologist
Florida
Primary
151659
Internal Medicine
Florida
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 442152, Miami, Florida
Zip:
33144-9152
Phone Number:
786-709-8862
Fax Number:
--
Patients can reach Dr. Renan Amador at 12151 Taft St, Pembroke Pines, Florida or can call to book an appointment on 954-704-1050. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.